Velivet recall: Impurity Out of Spec
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28…
Why was Velivet recalled?
Failed Impurities/Degradation Specifications: out of specification impurity test results.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot 33805449A, Exp. 12/14
- Product
- Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28…
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 5265 blister packs
- Distribution
- Nationwide
- Recall date
- July 23, 2014
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)